Overview
Status
Active
Registry date
2010-12-17
Share capital
130,000.00 PLN
Registered address
Poznańska 16/4, 00-680 Warszawa, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
- Management consultancy activities (70.2)
Authorized Representatives
Krzysztof Gawrysiak – Attorney-in-fact (sole)
Leszek Konrad Guzy – President of the Management Board
Manner of representation
Each member of the management board is entitled to make declarations of will on behalf of the company independently
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krzysztof Grzegorz Gawrysiakage 49 | 988 | $13,344.14 | 38% |
Piotr Grzybowskiage 64 | 650 | $8,779.04 | 25% |
Leszek Konrad Guzyage 68 | 962 | $12,992.98 | 37% |
Beneficial owners
No beneficial owners recorded for the company 23 Rs Coras.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
RS Petsp. z o.o. | 351,161.53 USD | 65% |
Bank accounts
Was a VAT taxpayer from 2014-07-28 to 2022-04-21.
Reason for removal: Art. 96 ust. 9 pkt 2 (contact with the taxpayer or their representative is impossible despite documented attempts)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| RDLSsp. z o.o. | $1,680,515.32 | rdls.pl | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic ScientificS.A. | $518,429.97 | orphinic.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Getgetsp. z o.o. | – | getget.pl | ||
| LASTsp. z o.o. | – | last-skincare.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-10-02 | PKD change (Removed: 13 codes; Added: 1 code) | |
| 2014-07-28 | Address change (Aleje Jerozolimskie 56c, 00-803, Warszawa → Poznańska 16/4, 00-680, Warszawa) | |
| 2014-07-28 | Share capital increase (10,000.00 PLN → 130,000.00 PLN) | |
| 2012-07-04 | Share capital increase (5,000.00 PLN → 10,000.00 PLN) | |
| 2012-07-04 | PKD change (Added: 14 codes) |
FAQ
The main business activity of 23 Rs Coras focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on December 17, 2010.
The headquarters is located at: Poznańska 16, 00-680 Warszawa.
The share capital of the company is PLN 130,000 (approx. $35,116).
Last updated: 2026-04-19